Literature DB >> 32092480

Radiofrequency echographic multi spectrometry for the prediction of incident fragility fractures: A 5-year follow-up study.

Giovanni Adami1, Giovanni Arioli2, Gerolamo Bianchi3, Maria Luisa Brandi4, Carla Caffarelli5, Luisella Cianferotti4, Davide Gatti1, Giuseppe Girasole3, Stefano Gonnelli5, Monica Manfredini2, Maurizio Muratore6, Eugenio Quarta7, Laura Quarta7.   

Abstract

PURPOSE: To investigate the effectiveness of the T-score values provided by Radiofrequency Echographic Multi Spectrometry (REMS) in the identification of patients at risk for incident osteoporotic fractures.
METHODS: A population of Caucasian women (30-90 years), enrolled from 2013 to 2016, underwent dual X-ray absorptiometry (DXA) and REMS scans at axial sites. The incidence of fragility fractures was assessed during a follow-up period up to 5 years. Afterwards, patients with and without incident fractures were stratified in two age-matched groups with a 1: 2 proportion (Group F' and Group NF', respectively). The performance of REMS T-score in discriminating between the two groups was quantitatively assessed and compared with DXA.
RESULTS: 1516 patients were enrolled and 1370 completed the follow-up (mean ± SD: 3.7 ± 0.8 years; range: 1.9-5.0 years). Fracture incidence was 14.0%. Age-matched groups included 175 fractured patients and 350 non-fractured ones, respectively (median age 70.2 [interquartile range: 61.0-73.3] and 67.3 [65.4-69.8] years, p-value ns). The groups resulted also balanced for height, weight and BMI (p-values ns). As expected, the differences in REMS T-score (for vertebral site, -2.9 [-3.6 to -1.9] in Group F', -2.2 [-2.9 to -1.2] in Group NF') and DXA T-score (-2.8 [-3.3 to -1.9] in Group F', -2.2 [-2.9 to -1.4] in Group NF') were statistically significant (p-value <0.001). Analogous results were obtained for femoral neck. Considering the T-score cut-off of -2.5, REMS identified Group F' patients with a sensitivity of 65.1% and specificity of 57.7% of (OR = 2.6, 95%CI: 1.77-3.76, p < 0.001), whereas DXA showed a sensitivity of 57.1% and a specificity of 56.3% (OR = 1.7, 95%CI: 1.20-2.51, p-value = 0.0032). For femoral neck, REMS sensitivity and specificity were 40.2% and 79.9%, respectively, with an OR of 2.81 (95%CI: 1.80-4.39, p < 0.001). DXA, instead, showed a sensitivity and specificity of 42.3% and 79.3%, respectively, with an OR of 2.68 (95%CI: 1.71-4.21, p < 0.001).
CONCLUSIONS: REMS T-score resulted an effective predictor for the risk of incident fragility fractures in a population-based sample of female subjects, representing a promising parameter to enhance osteoporosis diagnosis in the clinical routine.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone mineral density; DXA; Fragility fracture risk; Osteoporosis diagnosis; REMS; Ultrasound

Mesh:

Year:  2020        PMID: 32092480     DOI: 10.1016/j.bone.2020.115297

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  11 in total

Review 1.  Pulse-Echo Measurements of Bone Tissues. Techniques and Clinical Results at the Spine and Femur.

Authors:  Delia Ciardo; Paola Pisani; Francesco Conversano; Sergio Casciaro
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Clinical Devices for Bone Assessment.

Authors:  Kay Raum; Pascal Laugier
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

3.  Quantitative Ultrasound (QUS) in the Management of Osteoporosis and Assessment of Fracture Risk: An Update.

Authors:  Didier Hans; Antoine Métrailler; Elena Gonzalez Rodriguez; Olivier Lamy; Enisa Shevroja
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

4.  Evaluation of the bone mineral density in the Mexican female population using the Radiofrequency Echographic Multi Spectrometry (REMS) technology.

Authors:  Rosales-Ortiz Sergio; Rivera García Elaín Nayelli
Journal:  Arch Osteoporos       Date:  2022-03-07       Impact factor: 2.617

5.  New technology REMS for bone evaluation compared to DXA in adult women for the osteoporosis diagnosis: a real-life experience.

Authors:  Débora Meira Ramos Amorim; Eliane Naomi Sakane; Sergio Setsuo Maeda; Marise Lazaretti Castro
Journal:  Arch Osteoporos       Date:  2021-11-16       Impact factor: 2.617

6.  Radiofrequency echographic multispectrometry (REMS): an innovative technique for the assessment of bone status in young women with anorexia nervosa.

Authors:  Carla Caffarelli; Antonella Al Refaie; Michela De Vita; Maria Dea Tomai Pitinca; Arianna Goracci; Andrea Fagiolini; Stefano Gonnelli
Journal:  Eat Weight Disord       Date:  2022-07-28       Impact factor: 3.008

7.  Reproducibility and Accuracy of the Radiofrequency Echographic Multi-Spectrometry for Femoral Mineral Density Estimation and Discriminative Power of the Femoral Fragility Score in Patients with Primary and Disuse-Related Osteoporosis.

Authors:  Piera Lalli; Claudia Mautino; Chiara Busso; Francesca Bardesono; Marco Di Monaco; Lorenzo Lippi; Marco Invernizzi; Marco Alessandro Minetto
Journal:  J Clin Med       Date:  2022-06-29       Impact factor: 4.964

8.  Diagnostic, treatment, and follow-up of osteoporosis-position statement of the Latin American Federation of Endocrinology.

Authors:  O Gómez; A P Talero; M B Zanchetta; M Madeira; C A Moreira; C Campusano; A M Orjuela; S Cerdas P; M P de la Peña-Rodríguez; A A Reza; C Velazco; B Mendoza; L R Uzcátegui; P N Rueda
Journal:  Arch Osteoporos       Date:  2021-07-24       Impact factor: 2.617

9.  Osteoporosis in 10 years time: a glimpse into the future of osteoporosis.

Authors:  Giovanni Adami; Angelo Fassio; Davide Gatti; Ombretta Viapiana; Camilla Benini; Maria I Danila; Kenneth G Saag; Maurizio Rossini
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-03-20       Impact factor: 5.346

10.  Ability of radiofrequency echographic multispectrometry to identify osteoporosis status in elderly women with type 2 diabetes.

Authors:  Carla Caffarelli; Maria Dea Tomai Pitinca; Antonella Al Refaie; Elena Ceccarelli; Stefano Gonnelli
Journal:  Aging Clin Exp Res       Date:  2021-05-29       Impact factor: 3.636

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.